English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52710878    Online Users :  580
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"yap y s"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 1-10 of 19  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-05-11T08:25:41Z HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis Tan R.S.Y.C.; Ong W.S.; Lee K.-H.; Lim A.H.; Park S.; Park Y.H.; CHING-HUNG LIN; Lu Y.-S.; Ono M.; Ueno T.; Naito Y.; Onishi T.; Lim G.-H.; Tan S.-M.; Lee H.-B.; Ryu H.S.; Han W.; Tan V.K.M.; Wong F.-Y.; Im S.-A.; Tan P.H.; Chan J.Y.; Yap Y.-S.
臺大學術典藏 2022-03-10T06:15:00Z Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs Hata T.; Nakamura K.; Yonemori K.; Noguchi E.; Watanabe M.; Sohn J.; YEN-SHEN LU; Yap Y.-S.; Tamura K.; Fujiwara Y.
臺大學術典藏 2022-03-10T06:14:59Z An Overview of the Treatment Efficacy and Side Effect Profile of Pharmacological Therapies in Asian Patients with Breast Cancer YEN-SHEN LU; Yeo W.; Yap Y.-S.; Park Y.H.; Tamura K.; Li H.; Cheng R.
臺大學術典藏 2022-03-10T06:14:59Z Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens Dai M.S.; Feng Y.H.; Chen S.W.; Masuda N.; Yau T.; Chen S.T.; YEN-SHEN LU; Yap Y.S.; Ang P.C.S.; Chu S.C.; Kwong A.; Lee K.S.; Ow S.; Kim S.B.; Lin J.; Chung H.C.; Ngan R.; Kok V.C.; Rau K.M.; Sangai T.; Ng T.Y.; Tseng L.M.; Bryce R.; Bebchuk J.; Chen M.C.; Hou M.F.
臺大學術典藏 2021-08-31T06:29:21Z Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population Lin C.-H.; Yap Y.S.; Lee K.-H.; Im S.-A.; Naito Y.; Yeo W.; Ueno T.; Kwong A.; Li H.; Huang S.-M.; Leung R.; Han W.; Tan B.; Hu F.-C.; Huang C.-S.; ANN-LII CHENG; Lu Y.-S.; Asian Breast Cancer Cooperative Group
臺大學術典藏 2021-07-28T06:46:37Z Treating HR+/HER2? breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression Yeo W.; Ueno T.; CHING-HUNG LIN; Liu Q.; Lee K.-H.; Leung R.; Naito Y.; Park Y.H.; Im S.-A.; Li H.; Yap Y.S.; Lu Y.-S.; The Asian Breast Cancer Cooperative Group
臺大學術典藏 2021-07-28T06:46:37Z Insights into Breast Cancer in the East vs the West: A review Yap Y.-S.; Lu Y.-S.; Tamura K.; Lee J.E.; Ko E.Y.; Park Y.H.; Cao A.-Y.; CHING-HUNG LIN; Toi M.; Wu J.; Lee S.-C.
臺大學術典藏 2021-05-07T06:02:32Z Geographic Variation of Chronic Kidney Disease Prevalence: Correlation with the Incidence of Renal Cell Carcinoma or Urothelial Carcinoma? Yap Y.-S.;Chuang K.-W.;Chun-Ju Chiang;Chuang H.-Y.;Lu S.-N.; Yap Y.-S.; Chuang K.-W.; CHUN-JU CHIANG; Chuang H.-Y.; Lu S.-N.
臺大學術典藏 2021-04-26T08:05:27Z Palbociclib and beyond for the treatment of HR + HER2- metastatic breast cancer: an Asian-Pacific perspective and practical management guide on the use of CDK4/6 inhibitors Dawood S.;Chiu J.W.-Y.;Chiun-Sheng Huang;Nag S.;Sookprasert A.;Yap Y.-S.;Md Yusof M.; Dawood S.; Chiu J.W.-Y.; CHIUN-SHENG HUANG; Nag S.; Sookprasert A.; Yap Y.-S.; Md Yusof M.
臺大學術典藏 2021-03-10T02:36:32Z Response to Sung, Rosenberg, and Yang Lin C.-H.; Yap Y.S.; Lee K.-H.; Yeo W.; Ueno T.; Li H.; Huang S.-M.; YEN-SHEN LU

Showing items 1-10 of 19  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page